Despite widespread use in sick infants, it is still debated whether vasopressor-inotropes have direct cerebral effects that might affect neurological outcome. We aimed to test direct cerebrovascular effects of three commonly used vasopressor-inotropes (adrenaline, dopamine and noradrenaline) by comparing the responses to those of nonpharmacologically induced increases in blood pressure. We also searched for reasons for a mismatch between the response in perfusion and oxygenation.
Twenty-four piglets had long and short infusions of the three vasopressor-inotropes titrated to raise mean arterial blood pressure (MAP) 10 mmHg in random order. Nonpharmacological increases in MAP were induced by inflation of a balloon in the descending aorta. We measured cerebral oxygenation (near-infrared spectroscopy), perfusion (laser-Doppler), oxygen consumption (co-oximetry of arterial and superior sagittal sinus blood), and microvascular heterogeneity (side stream dark field video microscopy).
Vasopressor-inotropes increased cerebral oxygenation significantly less (p≤0.01) compared to non-pharmacological MAP increases, whereas perfusion was similar. Furthermore, cerebral total hemoglobin concentration increased significantly less during vasopressor-inotrope infusions (p = 0.001). These physiologic responses were identical between the three vasopressor-inotropes (p>0.05). Furthermore, they induced a mild, although insignificant increase in cerebral metabolism and microvascular heterogeneity (p>0.05). Removal of the scalp tissue did not influence the mismatch (p>0.05).
We demonstrated a moderate vasopressor-inotrope induced mismatch between cerebral perfusion and oxygenation. Scalp removal did not affect this mismatch, why vasopressor-inotropes appear to have direct cerebral actions. The statistically nonsignificant increases in cerebral metabolism and/or microvascular heterogeneity may explain the mismatch. Alternatively, it may simply reflect a vasopressor-inotrope-induced decrease in the arterial-to-venous volume ratio as detected by near-infrared spectroscopy.
Citation: Hahn GH, Hyttel-Sorensen S, Petersen SM, Pryds O, Greisen G (2013) Cerebral Effects of Commonly Used Vasopressor-Inotropes: A Study in Newborn Piglets. PLoS ONE 8(5): e63069. https://doi.org/10.1371/journal.pone.0063069
Editor: Shawn E. Bearden, Idaho State University, United States of America
Received: November 28, 2012; Accepted: March 27, 2013; Published: May 20, 2013
Copyright: © 2013 Hahn et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Lundbeck Foundation, Aase and Einar Danielsens Foundation and The Augustinus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Despite widespread use of antihypotensive therapy in sick newborn infants, controversy still exists as to whether adverse neurological outcome is caused by the antihypotensive therapy itself, by inappropriate administration of the therapy causing sudden alterations in the blood pressure or by the severity of the disease –. Since premature  and sick infants  have increased blood-brain barrier permeability, direct cerebrovascular as well as cerebral effects of antihypotensive therapy seem possible . Contribution of adrenergic mechanisms to cerebrovascular regulation may be relatively unique to the developing brain , . Thus, understanding how commonly used vasopressor-inotropes affect cerebrovascular mechanisms is of major clinical relevance in newborn infants.
Recently, an experimental study by our group suggested that dopamine, the most frequently used vasopressor-inotrope in sick infants, induces an unexplained mismatch between cerebral perfusion and oxygenation . Based on this finding we set out to investigate how three commonly used vasopressor-inotropes - adrenalin, dopamine and noradrenalin – might affect cerebral perfusion and oxygenation. Besides, we evaluated whether any mismatch could be attributable to (i) increased cerebral metabolism , , (ii) increased microvascular heterogeneity  or simply (iii) vasoconstriction in extracranial blood vessels contaminating the cerebral oxygenation-signal, thereby making near-infrared spectroscopy (NIRS) inappropriate to monitor preservation of cerebral oxygenation as a surrogate measure of cerebral blood flow during antihypotensive therapy in newborn infants .
Materials and Methods
The Danish Animal Experiments Inspectorate approved the experimental protocol (approval ID: 2009/561-1723).
Anesthesia and Monitoring
In 24 newborn piglets (median age: 1 day, range: 1–6 days; median weight: 1.7 kg, range: 1.3–2.1 kg) preanesthesia was induced by 3% isoflurane supplemented with an intravenous induction dose of propofol (5 mg/kg) and fentanyl (20 µg/kg). Subsequently, isoflurane inhalation was discontinued while intravenous propofol (15 mg/kg/h) was maintained throughout the experiment. Mechanical ventilation was instituted after tracheostomy and ventilator settings were adjusted to keep arterial saturation above 95% and arterial tension of CO2 between 4 to 6 kPa. Arterial oxygen saturation and pulse rate was monitored by pulse oximetry from the forepaw (Radical 7, Masimo, Hannover, Germany). Piglets were kept on a warming pad to maintain rectal temperature at 38.5–39.5°C.
The femoral arteries were cannulated with: (i) a pressure and blood gas monitoring line and (ii) a 4 Fr catheter with an inflatable balloon near its tip (Fogarty Fortis, Arterial Embolectomy Catheter, Edwards Lifesciences, USA). Inflation of this balloon occluded the lumen of the thoracic part of aorta resulting in a nonpharmacologically induced increase in blood pressure in the upper body. The femoral vein was cannulated with a central venous line (4 Fr double lumen catheter) for drug and fluid infusion (glucose 10%, 2.5 ml/kg/h). A craniotomy was performed in the right parietal region with a biopsy punch (diameter: 5 mm) for dural placement of a laser-doppler flowmetry (LDF) probe. In half of the piglets (n = 12) yet another transdural craniotomy was performed in the left parietal region for video microscopic measurements (diameter: 15 mm). This transdural craniotomy was protected by wet gauzes and desiccation was prevented by local administration of 2 ml saline solution (37°C) each quarter of an hour. Finally, a cannula (22 G) was inserted at the bregma into the sagittal sinus to permit repeated sampling of cerebral venous blood. Piglets recovered for 0.5 h after the surgical procedures.
All piglets received antibiotics (ampicillin: 200 mg/kg; gentamicin: 4 mg/kg) and saline (10 ml/kg) as a single dose prior to surgical preparation. All incisions were infiltrated with bupivacaine (2.5 mg/ml).
We used long and short infusions of the vasopressor-inotropes (adrenalin, dopamine and noradrenalin) titrated to raise mean arterial blood pressure (MAP) 10 mmHg as well as nonpharmacologically induced changes in MAP (Fig. 1 and 2). The long infusions were applied to study steady state responses and effect on cerebral metabolism and microvascular heterogeneity. The short repeated infusions were applied to differentiate the cerebral effects of vasopressor-inotropes from cerebral autoregulatory effects elicited by the systemic effect of the drugs. Nonpharmacologically induced changes in MAP were induced by repeated inflations of the thoracic balloon. The balloon was inflated 10 times, and inflations lasted 30 sec interspaced by 30 sec pauses (Fig. 2). Piglets rested for 10 min between each MAP intervention to ensure adequate washout/return to baseline. Thirty minutes after the drug infusion was stopped, the next drug was tested in the same way. Between each drug, a volume of six times the estimated catheter dead space (0.2 ml) was withdrawn from the catheter to prevent mixture of drug effects.
Baseline and steady state measurements included duplicate blood samples for metabolic measurements in all piglets and video microscopic examination of the cortical microvascular heterogeneity in of the 12 piglets. Blood pressure fluctuations were induced pharmacologically and nonpharmacologically to evaluate a possible direct drug induced effect on cerebral perfusion and oxygenation. PR, pulse rate; MAP, mean arterial blood pressure; SaO2, arterial oxygen saturation; LDF, laser Doppler flow; OI, oxygenation index; NIRS, near infrared spectroscopy.
Example of pharmacologically (first 10 min) and nonpharmacologically (last 10 min) induced changes in mean arterial blood pressure (MAP) and corresponding changes in cerebral perfusion (LDF in % from baseline) and oxygenation (OI measured with near infrared spectroscopy). Pharmacologically induced changes consisted of two repeated infusions lasting 2½ minute, interspaced with pauses lasting 2½ minute to reach baseline levels. This was followed by nonpharmacological MAP fluctuations induced by balloon inflations: the thoracic aorta balloon was inflated 10 times, and inflations lasted 30 sec interspaced by 30 sec pauses. The vertical line represents a 10 min pause between the induced changes in MAP.
The vasopressor-inotropes were tested in randomized and balanced order. The investigators were blinded to this randomization until end of data analysis.
Pulse rate, arterial oxygen saturation, MAP, cortical laser-doppler flow (LDF) and cerebral oxygenation were sampled continuously throughout the experiment (sampling rate: 2 Hz).
Cerebral Perfusion and Oxygenation
LDF monitored cerebral perfusion (Perimed 5010, Stockholm, Sweden). The probe was placed in a metal washer glued to the skull. LDF measures changes in red blood cell velocity in non-absolute values. Consequently, LDF values are expressed as percentage change compared to values averaged over the last minute before each intervention.
Near-infrared spectroscopy (NIRS) monitored cerebral oxygenation (NIRO-300 spectrophotometer, Hamamatsu Photonics, Hamamatsu City, Japan). The probes were fixed in a nontransparent, soft probe holder (interoptode distance: 4 cm) and placed on the skin. In 12 of the piglets (those who did not undergo video microscopic examination of microvascular heterogeneity), a second NIRS probe was placed directly on the skull to estimate a possible extracranial contribution to the NIRS-signal. Changes in the concentrations of oxygenated and deoxygenated hemoglobin were recorded and used to calculate the oxygenation index (OI). OI is the difference between oxygenated and deoxygenated hemoglobin divided by a factor of 2. It reflects changes in cerebral blood flow (CBF), provided constant levels of SaO2 and cerebral metabolism . The summation of oxygenated and deoxygenated hemoglobin represents the change in total hemoglobin (tHb), which reflects the change in cerebral blood volume within the illuminated area.
During the dynamic responses, i.e. during the short repeated infusions and the nonpharmacologically induced changes in MAP, frequency analysis yielding gain between MAP and percentage change in LDF (gain-LDF), OI (gain-OI) and tHb (gain-tHb) were computed for frequencies between 0.003 and 0.04 Hz (fluctuation time: 25–300 sec) (Matlab, Math Works, Natick, Maasachusetts). Gain measures change in output signal (here LDF, tHb and OI) per change in input signal (here MAP). Each 10-minute epoch of data was subdivided into three segments of 5 minutes with 50% overlap. A Hanning-window was applied to minimize spectral leakage. Both time-signals were then detrended and transformed into power spectrum densities by Fourier transformation (Matlab, MathWorks, Natick, MA).
Discerning the possible direct actions of vasopressor-inotropes on the cerebral circulation is complicated by their additional effects on the systemic circulation. Therefore, we compared gain during short repeated vasopressor-inotrope infusions and gain during nonpharmacologically induced changes in MAP to account for a possible indirect effect of cerebral autoregulation on cerebral vasculature elicited by a vasopressor-inotrope induced increase in MAP.
Venous (superior sagittal sinus) and arterial blood samples were obtained simultaneously and analyzed immediately (Radiometer, Copenhagen, Denmark). We estimated the cerebral arteriovenous oxygen content difference (AVDO2) according to the following formula:where Hb is hemoglobin, 1.39 is the oxygen carrying capacity of Hb, SaO2 is the arterial oxygen saturation, SvssO2 is the venous oxygen saturation in sinus sagittalis, PaO2 is the arterial oxygen tension, PvssO2 is the venous oxygen tension in sinus sagittalis, and 0.003 is the solubility of oxygen in blood. We used the mean of duplicate measurements to characterize AVDO2 in each state. Cerebral metabolic rate of oxygen (CMRO2) was calculated in relative values based on percentage change in LDF between baseline and steady state:
We used a side stream dark field video microscope (Microscan, MicroVision Medical Inc, Amsterdam, Netherlands) to evaluate possible alterations in cerebral microcirculatory heterogeneity. Basically, this is a handheld device that illuminates an area of 1.08×0.81 mm and penetrates 0.9 mm with light in a wavelength (580 nm) that is absorbed by red blood cells (RBC). In this way RBCs appear dark and visualize microcirculatory flow. Image acquisition and subsequent analyses were performed according to published consensus criteria . In brief, the lens of the imaging device was applied to the cerebral cortex, and absence of pressure artifacts was secured by preservation of flow in large vessels. Within the craniotomy, three recordings of 25 sec. each were recorded from different regions during both baseline and steady state. To minimize possible bias introduced by subjective flow classification, one investigator (S.M.P), who had no involvement in the data collection, performed all analyses. Furthermore, recordings were coded randomly and analyzed by means of a validated software package (Automated Vascular Analysis; AVA 3.0, MicroVision medical, Amsterdam, Netherlands) . The software performs automatic vessel recognition and measurement (length and diameter), whereas flow is classified by eye. We used proportion of perfused vessels (PPV; proportion of vessels with continuous or sluggish flow) to determine microvascular heterogeneity with regard to (i) anatomical distribution and (ii) vessel type. Anatomical heterogeneity index was calculated as the difference between the highest and lowest value of PPV divided by the mean of the three different regions investigated . This index was used to investigate whether vasopressor-inotropes increased flow in some areas but not in others. Vessel type heterogeneity index was calculated as PPV in capillaries (diameter <25µm) divided by PPV in all vessels. This index was used to investigate whether vasopressor-inotropess affected capillary flow differentially.
Parametric (paired Student’s t-test) or non-parametric (Wilcoxon Signed Rank Test) statistical methods were used as appropriate to test paired differences between baseline and steady state as well as between pharmacologically and nonpharmacologically induced MAP-changes. One-way repeated measures ANOVA was used to compare the cerebrovascular effects between the drugs and to investigate if gain during nonpharmacologically induced changes in MAP - as a measure of cerebral autoregulation – changed over time. A two-tailed p-value <0.05 was considered significant (SPSS statistics 17.0). Continuous data are reported in median [25th–75th]. Because of insufficient signal quality, one piglet was excluded from the study (n = 23), leaving 11 piglets with video microscopic examinations.
A median adrenaline dose of 0.6 [0.5–0.7] µg per kg pr min was used to increase MAP with 8 – mmHg. The equivalent dosages and responses were 25 – µg per kg pr min and 11 – mmHg for dopamine and 0.4 [0.4–0.4] µg per kg pr min and 8 – mmHg for noradrenaline. All three vasopressor-inotropes increased MAP significantly from baseline (p<0.001) (Table 1). From a cerebral hemodynamic point of view, the piglets stayed stable during the experiment, as their cerebral autoregulatory capacity – measured by means of gain-LDF and gain-OI during nonpharmacologically induced changes in MAP – did not change significantly during the experiment (p = 0.2 and p = 0.5, respectively).
During steady state, where additional effects on the systemic circulation were not accounted for, dopamine increased both cerebral perfusion and oxygenation significantly (p = 0.001 and p = 0.004, respectively). Adrenaline increased cerebral perfusion significantly (p = 0.002), whereas the increase in cerebral oxygenation did not reach significance (p = 0.06). Noradrenaline did not increase cerebral perfusion significantly (p = 0.07), whereas cerebral oxygenation increased significantly (p = 0.01) (Table 1). These responses, however, did not differ significantly among the vasopressor-inotropes (ANOVA p = 0.053 for perfusion and p = 0.7 for oxygenation) (Table 2).
To level out a possible masking effect of cerebral autoregulation on the cerebral response to vasopressor-inotrope infusion, we compared gain-LDF and gain-OI between pharmacologically and nonpharmacologically induced changes in MAP. Generally, we observed a mismatch between cerebral perfusion (gain-LDF) and oxygenation (gain-OI), as cerebral perfusion was similar while cerebral oxygenation was significantly lower, except for adrenaline, where the increase in cerebral perfusion was significantly lower compared to nonpharmacologically induced changes in MAP (Table 3). Again, however, these responses did not differ significantly among the vasopressor-inotropes (ANOVA: p = 0.5 and p = 0.8, for cerebral perfusion and oxygenation respectively) (Table 2).
Gain-tHb was significantly lower during vasopressor-inotrope infusions compared to non-pharmacologically induced changes in MAP, 0.09 [0.05–0.10]µM/mmHg and 0.11 [0.07–0.13] µM/mmHg, respectively (p = 0.001). The response did not differ significantly among the three vasopressor-inotropes (p>0.05). These numbers indicate an increase in cerebral blood volume during both pharmacologically and nonpharmacologically induced changes in MAP.
CMRO2 was not affected significantly by any of the vasopressor-inotropes, although we observed a mild increase in CMRO2. Likewise, we demonstrated an insignificant increase in microvascular heterogeneity during vasopressor-inotrope infusion. The anatomical heterogeneity index increased, and the vessel type heterogeneity index decreased, indicating a minor hypoperfusion (i) in some areas and (ii) in capillaries compared to all vessels, respectively (Table 1).
Cutaneous vasoconstriction did not influence the NIRS measurement of cerebral oxygenation. During steady state, the change in cerebral oxygenation was 1.03 [−0.01–2.09] µM, when the NIRS probe was placed on the skin, compared to 0.95 [−0.25–1.85], when the probe was placed directly on the skull (p = 0.053). Also, during short repeated infusions, we did not observe any differences: (0.07 [0.05–0.11] µM per mmHg on the skin and 0.06 [0.04–0.07] µM per mmHg on the skull; p = 0.2).
We tested how three commonly used vasopressor-inotropes – adrenaline, dopamine and noradrenaline - affect cerebral perfusion, oxygenation, metabolism, and microvascular heterogeneity in newborn piglets. To the best of our knowledge, we are first to investigate possible changes in cerebral microvascular heterogeneity during antihypotensive therapy. Also, we are first to test whether cerebral oxygenation, as measured with NIRS, is influenced by cutaneous vasoconstriction, and whether CMRO2 is affected during vasopressor-inotrope therapy in the newborn brain.
The direct effect of vasopressor-inotropes on the cerebral circulation remains contentious, and clinical studies in infants are conflicting. Besides different methods of measurements of cerebrovascular responses, the main cause of disagreement seems to be variability of the study population with a varying degree of (i) hypotension, (ii) impaired cerebral autoregulation and (iii) integrity of the blood-brain barrier. Cerebral autoregulation, the myogenic response that ensures a fairly constant cerebral blood flow within a wide range of arterial blood pressures, may be impaired in hypotensive infants –. This explains, why dopamine increases cerebral blood flow in hypotensive , – but not in normotensive infants , . Thus, to study a direct cerebral effect of vasopressor-inotropes, the myogenic component of cerebral autoregulation needs to be accounted for. In our study this was accomplished by contrasting the cerebral effect of pharmacologically and nonpharmacologically induced changes in blood pressure. In line with an earlier study by our group , we found a mismatch between cerebral perfusion and oxygenation, as oxygenation increased less than perfusion after administration of vasopressor-inotropes. Removing the scalp did not matter, so vasopressor-inotropes appear to have direct cerebral actions.
From an overall point of view, the three vasopressor-inotropes did not affect cerebral oxygenation or perfusion differently. Looking at individual differences during steady state, however, adrenaline apparently increased cerebral perfusion to a larger extent than dopamine and noradrenaline. This observation was not consistent with steady state changes in oxygenation or changes in perfusion or oxygenation during repeated infusions, where individual responses did not differ (Table 2). Therefore, we do not attach significance to this single observation.
The fact that cerebral oxygenation did not depend on whether the NIRS probe was placed on the skin or directly on the skull indicates that NIRS can be used to monitor preservation of cerebral oxygenation as a surrogate measure of cerebral blood flow during vasopressor-inotrope therapy. Contrary to our finding, experiments in adults generally report a significant extracranial contamination of the NIRS signal , which complicates the use of NIRS to monitor preservation of cerebral oxygenation during vasopressor-inotrope treatment . Differences in thickness of the scalp might explain this discrepancy.
CMRO2 did increase during vasopressor-inotrope therapy, but the change was small and statistically insignificant. Adult animal models have shown diverging results, with unaffected CMRO2 in some studies  and increased CMRO2 in others –, .
Heterogenic microvascular perfusion is associated with an increased median oxygen diffusion distance . Consequently, an increase in the heterogeneity of cerebral perfusion – by vasopressor-inotrope therapy increasing flow in some microvascular territories but not in others – will leave the oxygenation in those vascular beds unchanged, and hence the average cerebral oxygenation at the regional level will be increased proportionally less. Overall, we demonstrated a statistical insignificant increase in anatomical heterogeneity and a statistical insignificant decrease in flow in capillaries compared to all vessels. We made use of a large number of tests to evaluate heterogeneity. This necessitates an overall view. Therefore, we do not ascribe significance to the fact that adrenaline apparently decreased anatomical heterogeneity for all vessels but not for capillaries. We are unaware of other studies investigating possible changes in cerebral microvascular heterogeneity during vasopressor infusion.
It is possible that the increases in cerebral metabolism and microvascular heterogeneity, although statistically insignificant, may explain the observed mismatch between cerebral perfusion and oxygenation. Alternatively, a change in the arterio-venous volume ratio as seen by NIRS , may explain it. To investigate this possibility, we used a manual iterative approach to estimate vasopressor-inotrope induced changes in the arterial-to-venous volume ratio that might explain the measured changes in cerebral oxygenation (OI) and cerebral blood volume (tHb). This approach demonstrated that the arterial-to-venous volume ratio should only change as little as 1% in order to be able to explain the observed mismatch (see Appendix S1).
Besides the already discussed methodological consideration regarding the NIRS technology, the main methodological considerations are as follows. Firstly, even though we studied a rather large and homogenous group of piglets that from a cerebral hemodynamic point of view stayed stable during the experiment, large inter-individual and intra-individual differences were observed. This, unfortunately, increases the likelihood of a type II error. Secondly, although newborn piglets have anatomical, physiological and developmental similarities with the human term infant , , it is difficult to extend results obtained in a piglet model to human infants. Thirdly, findings in normotensive animals might not correspond to those in animals with cardiovascular compromise . Fourthly, we did not account for the fact, that the balloon-inflations induce a decrease in perfusion and oxygen delivery to the tissue distal to the balloon, which might trigger an autonomic feedback to the brain. However, as demonstrated in Fig. 2, the cerebral response to these stimulations did not change over a period of time. Furthermore, lactate did not accumulate in the piglets. So in other words, our model seems stable in spite of this limitation.
In conclusion, we demonstrated a moderate vasopressor-inotrope induced mismatch between cerebral perfusion and oxygenation. Removing the scalp did not matter, so vasopressor-inotropes appear to have direct cerebral actions. The statistically nonsignificant increases in cerebral metabolism and/or microvascular heterogeneity may explain the mismatch. Alternatively, it may simply reflect a vasopressor-inotrope-induced decrease in the arterial-to-venous volume ratio as detected by near-infrared spectroscopy. Given the large population of sick infants who are treated with vasopressor-inotropes, further studies to elucidate possible direct cerebral effects in the newborn brain are warranted.
Conceived and designed the experiments: GHH GG OP. Performed the experiments: GHH SHS OP. Analyzed the data: GHH SMP GG. Wrote the paper: GHH GG OP SHS.
- 1. Fanaroff JM, Wilson-Costello DE, Newman NS, Montpetite MM, Fanaroff AA (2006) Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants. Pediatrics 117: 1131–1135.
- 2. Gronlund JU, Kero P, Korvenranta H, Aarimaa T, Jalonen J, et al. (1995) Cerebral circulation assessed by transcephalic electrical impedance during the first day of life–a potential predictor of outcome? Early Hum Dev 41: 129–145.
- 3. Synnes AR, Chien LY, Peliowski A, Baboolal R, Lee SK (2001) Variations in intraventricular hemorrhage incidence rates among Canadian neonatal intensive care units. J Pediatr 138: 525–531.
- 4. Sassano-Higgins S, Friedlich P, Seri I (2011) A meta-analysis of dopamine use in hypotensive preterm infants: blood pressure and cerebral hemodynamics. J Perinatol 31: 1–9.
- 5. Seri I, Tulassay T, Kiszel J, Sulyo E, Ertl T, et al. (1984) Effect of low-dose dopamine therapy on catecholamine values in cerebrospinal fluid in preterm neonates. J Pediatr 105: 489–491.
- 6. Kumar A, Mittal R, Khanna HD, Basu S (2008) Free radical injury and blood-brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics 122: e722–e727.
- 7. Wong FY, Barfield CP, Horne RS, Walker AM (2009) Dopamine therapy promotes cerebral flow-metabolism coupling in preterm infants. Intensive Care Med 35: 1777–1782.
- 8. Wagerle LC, Kurth CD, Roth RA (1990) Sympathetic reactivity of cerebral arteries in developing fetal lamb and adult sheep. Am J Physiol 258: H1432–H1438.
- 9. Bevan R, Dodge J, Nichols P, Poseno T, Vijayakumaran E, et al. (1998) Responsiveness of human infant cerebral arteries to sympathetic nerve stimulation and vasoactive agents. Pediatr Res 44: 730–739.
- 10. Hahn GH, Heiring C, Pryds O, Greisen G (2012) Cerebral vascular effects of hypovolemia and dopamine infusions: a study in newborn piglets. Acta Paediatr 101(7): 736–42.
- 11. Edvinsson L, Krause DN (2002) Cerebral Blood Flow and Metabolism. 2. ed: 191–211.
- 12. Ekstrom-Jodal B, Larsson LE (1982) Effects of dopamine of cerebral circulation and oxygen metabolism in endotoxic shock: an experimental study in dogs. Crit Care Med 10: 375–377.
- 13. De Backer D, Ospina-Tascon G, Salgado D, Favory R, Creteur J, et al. (2010) Monitoring the microcirculation in the critically ill patient: current methods and future approaches. Intensive Care Med 36: 1813–1825.
- 14. Davie SN, Grocott HP (2012) Impact of extracranial contamination on regional cerebral oxygen saturation: a comparison of three cerebral oximetry technologies. Anesthesiology 116: 834–840.
- 15. Tsuji M, duPlessis A, Taylor G, Crocker R, Volpe JJ (1998) Near infrared spectroscopy detects cerebral ischemia during hypotension in piglets. Pediatr Res 44: 591–595.
- 16. De Backer D, Hollenberg S, Boerma C, Goedhart P, Buchele G, et al.. (2007) How to evaluate the microcirculation: report of a round table conference. Crit Care 11: R101–
- 17. Dobbe JG, Streekstra GJ, Atasever B, van Zijderveld R, Ince C (2008) Measurement of functional microcirculatory geometry and velocity distributions using automated image analysis. Med Biol Eng Comput 46: 659–670.
- 18. Trzeciak S, Dellinger RP, Parrillo JE, Guglielmi M, Bajaj J, et al.. (2007) Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 49: 88–98, 98.
- 19. Munro MJ, Walker AM, Barfield CP (2004) Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 114: 1591–1596.
- 20. Hahn GH, Maroun LL, Larsen N, Hougaard DM, Sorensen LC, et al. (2012) Cerebral autoregulation in the first day after preterm birth: no evidence of association with systemic inflammation. Pediatr Res 71: 253–260.
- 21. Borch K, Lou HC, Greisen G (2010) Cerebral white matter blood flow and arterial blood pressure in preterm infants. Acta Paediatr 99: 1489–1492.
- 22. Pellicer A, Valverde E, Elorza MD, Madero R, Gaya F, et al. (2005) Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics 115: 1501–1512.
- 23. Zhang J, Penny DJ, Kim NS, Yu VY, Smolich JJ (1999) Mechanisms of blood pressure increase induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fetal Neonatal Ed 81: F99–F104.
- 24. Jayasinghe D, Gill AB, Levene MI (2003) CBF reactivity in hypotensive and normotensive preterm infants. Pediatr Res 54: 848–853.
- 25. Seri I, Abbasi S, Wood DC, Gerdes JS (1998) Regional hemodynamic effects of dopamine in the sick preterm neonate. J Pediatr 133: 728–734.
- 26. Lundstrom K, Pryds O, Greisen G (2000) The haemodynamic effects of dopamine and volume expansion in sick preterm infants. Early Hum Dev 57: 157–163.
- 27. Sorensen H, Secher NH, Siebenmann C, Nielsen HB, Kohl-Bareis M, et al.. (2012) Cutaneous Vasoconstriction Affects Near-infrared Spectroscopy Determined Cerebral Oxygen Saturation during Administration of Norepinephrine. Anesthesiology.
- 28. Myburgh JA, Upton RN, Grant C, Martinez A (2002) The cerebrovascular effects of adrenaline, noradrenaline and dopamine infusions under propofol and isoflurane anaesthesia in sheep. Anaesth Intensive Care 30: 725–733.
- 29. McCulloch J, Harper AM (1977) Cerebral circulation: effect of stimulation and blockade of dopamine receptors. Am J Physiol 233: H222–H227.
- 30. Wong FY, Alexiou T, Samarasinghe T, Brodecky V, Walker AM (2010) Cerebral arterial and venous contributions to tissue oxygenation index measured using spatially resolved spectroscopy in newborn lambs. Anesthesiology 113: 1385–1391.
- 31. Armstead WM (2000) Age-dependent cerebral hemodynamic effects of traumatic brain injury in newborn and juvenile pigs. Microcirculation 7: 225–235.
- 32. Chapados I, Cheung PY (2008) Not All Models Are Created Equal: Animal Models to Study Hypoxic-Ischemic Encephalopathy of the Newborn Commentary on Gelfand SL et al.: A New Model of Oxidative Stress in Rat Pups (Neonatology 2008; 94: 293–299). Neonatology 94: 300–303.